Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic

Dig Liver Dis. 2021 Mar;53(3):295-297. doi: 10.1016/j.dld.2020.10.021. Epub 2020 Oct 19.

Authors

Anuraag Jena¹, Praveen Kumar-M¹, Anupam Kumar Singh¹, Vishal Sharma²

Affiliations

¹ Department of Gastroenterology and Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
² Department of Gastroenterology and Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India. Electronic address: sharma.vishal@pgimer.edu.in.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Feces
Humans
Inflammation
Inflammatory Bowel Diseases* / epidemiology
Leukocyte L1 Antigen Complex
Pandemics
SARS-CoV-2

Substances

Leukocyte L1 Antigen Complex